Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Frontiers in Oncology
|
February 27, 2026
Association between splenic volume changes and prognosis in advanced gastric cancer patients receiving chemotherapy combined with immunotherapy
Zhiying Li, Weiwei Liu, Guilin Zhang, et al.
Frontiers in Immunology
|
February 13, 2024
The impact of pulmonary artery to ascending aorta diameter ratio progression on the prognosis of NSCLC patients treated with immune checkpoint inhibitors
Bingxin Gong, Yi Li, Yusheng Guo, et al.
BMC Cancer
|
April 26, 2024
Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
Yi Li, Bingxin Gong, Yusheng Guo, et al.
Cancer Treatment and Research Communications
|
February 5, 2026
Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective study
Dongyong Zhu, Yusheng Guo, Weiwei Liu, et al.
Therapeutic Advances in Medical Oncology
|
October 30, 2025
Clinical significance of AFP and PIVKA-II for predicting prognosis in hepatocellular carcinoma patients treated with immune checkpoint inhibitors
Shanshan Jiang, Yuyang Wang, Xiaona Fu, et al.
Annals of Medicine
|
July 22, 2025
Extracellular volume fraction quantification by equilibrium contrast-enhanced CT via automated segmentation predicts survival outcomes in bladder cancer: a propensity score-matched study
Weiwei Liu, Yusheng Guo, Bingxin Gong, et al.
Translational Lung Cancer Research
|
June 15, 2026
Dynamic changes in liver-to-spleen ratio: can it be a prognostic biomarker for chemo-immunotherapy in small cell lung cancer?
Yi Ren, Weiwei Liu, Jie Lou, et al.
BMC Medical Imaging
|
July 6, 2026
Development of multiphasic CT-based delta-radiomics model for predicting postoperative recurrence risk in bladder cancer
Weiwei Liu, Bingxin Gong, Guilin Zhang, et al.
Insights Into Imaging
|
October 25, 2025
Mediation and prognostic value of apparent diffusion coefficient in HCC patients receiving immune checkpoint inhibitors
Xiaona Fu, Yusheng Guo, Yanjie Yang, et al.
Scientific Reports
|
September 8, 2024
MRI-measured periprostatic to subcutaneous adipose tissue thickness ratio as an independent risk factor in prostate cancer patients undergoing radical prostatectomy
Shanshan Jiang, Yi Li, Yusheng Guo, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Frontiers in Oncology
|
February 27, 2026
Association between splenic volume changes and prognosis in advanced gastric cancer patients receiving chemotherapy combined with immunotherapy
Zhiying Li, Weiwei Liu, Guilin Zhang, et al.
Frontiers in Immunology
|
February 13, 2024
The impact of pulmonary artery to ascending aorta diameter ratio progression on the prognosis of NSCLC patients treated with immune checkpoint inhibitors
Bingxin Gong, Yi Li, Yusheng Guo, et al.
BMC Cancer
|
April 26, 2024
Non-small cell lung cancer and immune checkpoint inhibitor therapy: does non-alcoholic fatty liver disease have an effect?
Yi Li, Bingxin Gong, Yusheng Guo, et al.
Cancer Treatment and Research Communications
|
February 5, 2026
Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective study
Dongyong Zhu, Yusheng Guo, Weiwei Liu, et al.
Therapeutic Advances in Medical Oncology
|
October 30, 2025
Clinical significance of AFP and PIVKA-II for predicting prognosis in hepatocellular carcinoma patients treated with immune checkpoint inhibitors
Shanshan Jiang, Yuyang Wang, Xiaona Fu, et al.
Annals of Medicine
|
July 22, 2025
Extracellular volume fraction quantification by equilibrium contrast-enhanced CT via automated segmentation predicts survival outcomes in bladder cancer: a propensity score-matched study
Weiwei Liu, Yusheng Guo, Bingxin Gong, et al.
Translational Lung Cancer Research
|
June 15, 2026
Dynamic changes in liver-to-spleen ratio: can it be a prognostic biomarker for chemo-immunotherapy in small cell lung cancer?
Yi Ren, Weiwei Liu, Jie Lou, et al.
BMC Medical Imaging
|
July 6, 2026
Development of multiphasic CT-based delta-radiomics model for predicting postoperative recurrence risk in bladder cancer
Weiwei Liu, Bingxin Gong, Guilin Zhang, et al.
Insights Into Imaging
|
October 25, 2025
Mediation and prognostic value of apparent diffusion coefficient in HCC patients receiving immune checkpoint inhibitors
Xiaona Fu, Yusheng Guo, Yanjie Yang, et al.
Scientific Reports
|
September 8, 2024
MRI-measured periprostatic to subcutaneous adipose tissue thickness ratio as an independent risk factor in prostate cancer patients undergoing radical prostatectomy
Shanshan Jiang, Yi Li, Yusheng Guo, et al.
Page
of 3